Table 5 Subgroup analysis using independent sample t-test to compare TWL & EWL at 6-, 12- and 24-months PO with regards to presence/absence of T2D or prediabetes, HT and HL at baseline; *p < 0.05 (statistically significant).

TWL & T2D/prediabetes

N (32)

N (29)

N (24)

 Absence

28.5 ± 7.9

0.6

37.8 ± 7.8

0.76

37.4 ± 9

0.94

 Presence

29.4 ± 7

37.2 ± 7.3

37.3 ± 8

TWL & HT

N (23)

N (22)

N (19)

 Absence

29.1 ± 7.5

0.85

37.8 ± 9.8

0.42

35.6 ± 10.4

0.85

 Presence

29.5 ± 8.5

35.6 ± 7.0

36.3 ± 9.9

TWL & HL

N (32)

N (28)

N (23)

 Absence

27.2 ± 9.5

0.56

35.2 ± 9.2

0.72

34.6 ± 8.2

0.6

 Presence

28.6 ± 6.2

35.9 ± 7.8

35.9 ± 8.2

EWL & T2D/prediabetes

N (32)

N (29)

N (24)

 Absence

61.8 ± 16.4

0.94

83.2 ± 17.7

0.34

83.8 ± 21.8

0.38

 Presence

62.1 ± 19.2

78.5 ± 19.3

79.3 ± 19.2

EWL & HT

N (23)

N (23)

N (19)

 Absence

63.2 ± 17.5

0.85

80.1 ± 20.3

0.74

78.4 ± 21.6

0.83

 Presence

61.1 ± 22.2

83.5 ± 39.7

76.6 ± 22.4

EWL & HL

N (28)

N (29)

N (23)

 Absence

58 ± 21.0

0.26

76 ± 19.5

0.31

79.1 ± 201.1

0.52

 Presence

63 ± 2 5.8

84 + 34.8

76.2 ± 17.3